Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.

Further Reading

Trial shows promising results for new medicine in treating severe asthma patients

Trial shows promising results for new medicine in treating severe asthma patients

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

New findings could lead to first broadly effective ebolavirus therapies and vaccines

New findings could lead to first broadly effective ebolavirus therapies and vaccines

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Patients with inducible urticaria can benefit from treatment with asthma drug

Patients with inducible urticaria can benefit from treatment with asthma drug

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

Experimental treatment cures Marburg and Ravn virus infection in animals

Experimental treatment cures Marburg and Ravn virus infection in animals

Researchers track in real-time how melanoma cells move to form tumors

Researchers track in real-time how melanoma cells move to form tumors

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

New study provides reassuring information about safety of osteoporosis drug

New study provides reassuring information about safety of osteoporosis drug

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

EuroPrevent 2017 to explore innovative ideas in preventive cardiology

EuroPrevent 2017 to explore innovative ideas in preventive cardiology

Scientists reveal new mRNA method to deliver safe, cost-effective therapeutic antibodies

Scientists reveal new mRNA method to deliver safe, cost-effective therapeutic antibodies

Study shows new drug as promising treatment option for difficult-to-treat rheumatoid arthritis patients

Study shows new drug as promising treatment option for difficult-to-treat rheumatoid arthritis patients

New anti-cocaine monoclonal antibody moves forward towards clinical studies in humans

New anti-cocaine monoclonal antibody moves forward towards clinical studies in humans

Scientists propose potential new treatment for Gaucher disease

Scientists propose potential new treatment for Gaucher disease

Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD

Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD

Preterm babies given monoclonal antibody appear less likely to develop recurrent wheeze

Preterm babies given monoclonal antibody appear less likely to develop recurrent wheeze

Study to investigate effectiveness of novel combination treatment for eradicating HIV

Study to investigate effectiveness of novel combination treatment for eradicating HIV